Caroline Young - 01 Dec 2021 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Caroline Young by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
01 Dec 2021
Net transactions value
+$1,790
Form type
4
Filing time
07 Jan 2022, 16:12:28 UTC
Previous filing
03 Dec 2021
Next filing
29 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $74.52 +18 +0.13% $4.14 14,401 01 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $69.12 +18 +0.12% $3.84 14,419 02 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $80.46 +18 +0.12% $4.47 14,437 03 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $80.28 +18 +0.12% $4.46 14,455 06 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $101 +18 +0.12% $5.61 14,473 07 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $111 +18 +0.12% $6.15 14,491 08 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $105 +18 +0.12% $5.81 14,509 09 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $86.76 +18 +0.12% $4.82 14,527 10 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $131 +30 +0.21% $4.36 14,557 13 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $128 +30 +0.21% $4.28 14,587 14 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $129 +30 +0.21% $4.29 14,617 15 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $226 +50 +0.34% $4.53 14,667 16 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $208 +50 +0.34% $4.17 14,717 17 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $260 +60 +0.41% $4.33 14,777 20 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.